Viveve Medical: Surges on positive study results

Viveve Medical

25/08/2020 11:58

** Shares of medical devices maker  VIVE.O  jump 77.4% to
$0.94 premarket, their highest level since early April
    ** Stock eyes its best day in nearly six years
    ** Co says its three-arm, five-month Stress Urinary
Incontinence feasibility study achieved its primary endpoint  urn:newsml:reuters.com:*:nACSBBY63a
    ** VIVE also announces positive pre-clinical outcomes that
support its PURSUIT Stress Urinary Incontinence trial
    ** Up to Monday's close, VIVE down nearly 58% YTD

 (Reporting by Ambar Warrick in Bengaluru)
 ((Ambar.Warrick@thomsonreuters.com; +91-80-6182-2837; Reuters
Messaging: ambar.warrick.thomsonreuters.com@reuters.net;
Twitter: @AmbarWarrick))